| Recruiting | A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) Solid Tumors, Adult | Phase 1 / Phase 2 | 2026-03-02 |
| Not Yet Recruiting | A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondropla Achondroplasia | Phase 1 / Phase 2 | 2025-12-10 |
| Not Yet Recruiting | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib Non-Small Cell Lung Cancer | Phase 2 | 2025-10-25 |
| Completed | A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Pro Pharmacokinetics in Healthy Volunteers | Phase 1 | 2025-09-12 |
| Recruiting | A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors Solid Tumors (Phase 1) | Phase 1 | 2025-07-22 |
| Recruiting | A Study in Children With Achondroplasia Achondroplasia | — | 2025-06-20 |
| Recruiting | ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression Hepatocellular Carcinoma (HCC) | Phase 2 | 2025-06-13 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Pa Healthy | Phase 1 | 2025-05-17 |
| Completed | A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects Pharmacokinetics | Phase 1 | 2025-05-13 |
| Active Not Recruiting | A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy Subjects Healthy Subjects | Phase 1 | 2025-04-08 |
| Not Yet Recruiting | A Mass Balance Study of [14C]ABSK011 Healthy Subjects | Phase 1 | 2025-04-07 |
| Completed | A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuva Healthy Subjects | Phase 1 | 2025-03-14 |
| Completed | A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy Subjects Pharmacokinetics | Phase 1 | 2024-12-10 |
| Recruiting | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib Non-Small Cell Lung Cancer With EGFR Mutation | Phase 2 | 2024-11-25 |
| Recruiting | A Phase 2 Clinical Study of ABSK061 and ABSK043 HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer | Phase 2 | 2024-11-13 |
| Completed | The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Pharmacokinetics | Phase 1 | 2024-09-20 |
| Completed | A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021 Healthy Subjects | Phase 1 | 2024-03-22 |
| Completed | A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules Healthy Subjects | Phase 1 | 2024-02-23 |
| Recruiting | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung C Non-Small Cell Lung Cancer | Phase 1 | 2024-02-22 |
| Completed | A Mass Balance Study of [14C]ABSK021 Healthy Subjects | Phase 1 | 2023-12-13 |
| Recruiting | A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 2 | 2023-10-17 |
| Active Not Recruiting | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tum Solid Tumor | Phase 1 | 2023-06-26 |
| Enrolling By Invitation | A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chroni cGvHD | Phase 2 | 2023-05-30 |
| Active Not Recruiting | Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath | Phase 3 | 2023-04-27 |
| Completed | A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021 Healthy Subjects | Phase 1 | 2023-04-11 |
| Unknown | A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC Urothelial Carcinoma | Phase 2 | 2022-09-30 |
| Completed | ABSK021 Food Effect Study in Healthy Subjects Neoplasms | Phase 1 | 2022-07-23 |
| Recruiting | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2022-06-30 |
| Enrolling By Invitation | A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients Hepatocellular Carcinoma | Phase 2 | 2021-12-30 |
| Unknown | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor Neoplasms | Phase 1 | 2021-08-31 |
| Unknown | A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2021-07-21 |
| Unknown | A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 Urothelial Carcinoma | Phase 1 / Phase 2 | 2021-06-03 |
| Completed | ABSK091 Food Effect Study in Healthy Subjects Health, Subjective, Food-drug Interaction | Phase 1 | 2020-09-08 |
| Recruiting | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid T Advanced Liver Cancer | Phase 1 | 2020-02-26 |
| Recruiting | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid T Neoplasms, Tenosynovial Giant Cell Tumor | Phase 1 | 2020-01-20 |